4.1 Article

BAYESIAN HIERARCHICAL MODELING FOR DETECTING SAFETY SIGNALS IN CLINICAL TRIALS

期刊

JOURNAL OF BIOPHARMACEUTICAL STATISTICS
卷 21, 期 5, 页码 1006-1029

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/10543406.2010.520181

关键词

Bayesian hierarchical models; Clinical trials; Drug safety; Multiplicity; Signal detection

向作者/读者索取更多资源

Detection of safety signals from clinical trial adverse event data is critical in drug development, but carries a challenging statistical multiplicity problem. Bayesian hierarchical mixture modeling is appealing for its ability to borrow strength across subgroups in the data, as well as moderate extreme findings most likely due merely to chance. We implement such a model for subject incidence (Berry and Berry, 2004) using a binomial likelihood, and extend it to subject-year adjusted incidence rate estimation under a Poisson likelihood. We use simulation to choose a signal detection threshold, and illustrate some effective graphics for displaying the flagged signals.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据